DM drug that promotes the release of endogenous insulin is initiated to improve glucose control=
DPP-4 inhibitors prevent the early breakdown of incretins, which promote endogenous insulin release.
(Sitagliptin is an example of this class of inhibitors.) They are generally used once metformin, diet, exercise, weight loss, or additional medications have failed to appropriately control a patient's blood glucose.
submitted by โnamesthegame22(13)
DM drug that promotes the release of endogenous insulin is initiated to improve glucose control=
DPP-4 inhibitors prevent the early breakdown of incretins, which promote endogenous insulin release.
(Sitagliptin is an example of this class of inhibitors.) They are generally used once metformin, diet, exercise, weight loss, or additional medications have failed to appropriately control a patient's blood glucose.